Phibro Animal Health Corporation (PAHC) Financial Ratios
26 years of historical data (2000–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
↓
19.67
↑+68% vs avg
5yr avg: 11.68
30Y Low9.7·High17.0
P/FCF
↓
56.82
↑+69% vs avg
5yr avg: 33.70
30Y Low14.7·High74.5
P/B Ratio
↓
8.35
↑+159% vs avg
5yr avg: 3.22
30Y Low2.0·High52.3
ROE
↓
17.8%
↓+17% vs avg
5yr avg: 15.2%
30Y Low-85%·High269%
Debt/EBITDA
↑
4.88
+3% vs avg
5yr avg: 4.76
30Y Low2.5·High10.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PAHC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Phibro Animal Health Corporation trades at 49.3x earnings, 31% below its 5-year average of 71.0x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 123%. On a free-cash-flow basis, the stock trades at 56.8x P/FCF, 69% above the 5-year average of 33.7x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.4B | $1.0B | $680M | $555M | $775M | $1.2B | $1.1B | $1.3B | $1.9B | $1.5B | $746M |
| Enterprise Value | $3.1B | $1.7B | $1.1B | $1.0B | $1.2B | $1.5B | $1.4B | $1.6B | $2.1B | $1.7B | $1.1B |
| P/E Ratio → | 49.28 | 21.46 | 279.50 | 16.91 | 15.81 | 21.55 | 31.65 | 23.53 | 28.60 | 23.01 | 9.01 |
| P/S Ratio | 1.83 | 0.80 | 0.67 | 0.57 | 0.82 | 1.40 | 1.33 | 1.55 | 2.27 | 1.94 | 0.99 |
| P/B Ratio | 8.35 | 3.64 | 2.65 | 1.96 | 2.95 | 4.90 | 5.65 | 5.96 | 10.06 | 9.80 | 8.25 |
| P/FCF | 56.82 | 24.85 | 14.66 | — | — | 61.61 | 42.05 | 74.51 | 36.15 | 19.12 | 861.89 |
| P/OCF | 29.67 | 12.97 | 7.76 | 41.69 | 24.48 | 24.21 | 17.93 | 27.29 | 26.57 | 15.06 | 20.05 |
P/E links to full P/E history page with 30-year chart
PAHC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Phibro Animal Health Corporation's enterprise value stands at 19.7x EBITDA, 68% above its 5-year average of 11.7x. The Healthcare sector median is 14.1x, placing the stock at a 39% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.34 | 1.11 | 1.05 | 1.24 | 1.86 | 1.80 | 1.88 | 2.61 | 2.28 | 1.42 |
| EV / EBITDA | 19.67 | 11.10 | 12.68 | 9.67 | 10.48 | 14.48 | 14.17 | 15.43 | 17.03 | 14.04 | 9.76 |
| EV / EBIT | 27.80 | 17.12 | 34.50 | 14.21 | 13.87 | 19.74 | 20.77 | 18.27 | 21.27 | 17.85 | 11.38 |
| EV / FCF | — | 41.43 | 24.47 | — | — | 81.44 | 56.84 | 90.06 | 41.66 | 22.44 | 1230.38 |
PAHC Profitability
Margins and return-on-capital ratios measuring operating efficiency
Phibro Animal Health Corporation earns an operating margin of 8.5%. Operating margins have expanded from 7.3% to 8.5% over the past 3 years, signaling improving operational efficiency. ROE of 17.8% indicates solid capital efficiency. ROIC of 9.8% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.9% | 30.9% | 30.8% | 30.5% | 30.3% | 32.6% | 32.1% | 32.0% | 32.5% | 32.5% | 31.8% |
| Operating Margin | 8.5% | 8.5% | 5.2% | 7.3% | 8.4% | 9.0% | 8.6% | 8.9% | 12.1% | 12.8% | 11.4% |
| Net Profit Margin | 3.7% | 3.7% | 0.2% | 3.3% | 5.2% | 6.5% | 4.2% | 6.6% | 7.9% | 8.5% | 11.0% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 17.8% | 17.8% | 0.9% | 12.0% | 19.6% | 25.5% | 16.6% | 27.3% | 38.6% | 53.5% | 137.7% |
| ROA | 4.1% | 4.1% | 0.2% | 3.4% | 5.5% | 6.7% | 4.4% | 7.8% | 10.0% | 10.5% | 15.0% |
| ROIC | 9.8% | 9.8% | 5.5% | 7.6% | 9.3% | 9.5% | 9.9% | 11.5% | 16.9% | 18.0% | 18.4% |
| ROCE | 12.0% | 12.0% | 6.8% | 9.4% | 11.1% | 11.5% | 11.5% | 13.3% | 19.1% | 19.4% | 19.4% |
PAHC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Phibro Animal Health Corporation carries a Debt/EBITDA ratio of 4.9x, which is highly leveraged (50% above the sector average of 3.3x). Net debt stands at $694M ($762M total debt minus $68M cash). Interest coverage of 3.0x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.67 | 2.67 | 2.05 | 1.81 | 1.79 | 1.79 | 2.18 | 1.51 | 1.69 | 2.07 | 3.90 |
| Debt / EBITDA | 4.88 | 4.88 | 5.87 | 4.82 | 4.21 | 4.00 | 4.05 | 3.23 | 2.48 | 2.53 | 3.23 |
| Net Debt / Equity | — | 2.43 | 1.77 | 1.66 | 1.51 | 1.58 | 1.99 | 1.24 | 1.53 | 1.70 | 3.53 |
| Net Debt / EBITDA | 4.44 | 4.44 | 5.08 | 4.43 | 3.55 | 3.53 | 3.69 | 2.66 | 2.25 | 2.07 | 2.92 |
| Debt / FCF | — | 16.58 | 9.81 | — | — | 19.83 | 14.80 | 15.55 | 5.50 | 3.32 | 368.48 |
| Interest Coverage | 3.04 | 3.04 | 1.50 | 4.01 | 6.98 | 7.53 | 4.84 | 6.23 | 7.41 | 5.77 | 5.56 |
PAHC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Phibro Animal Health Corporation's current ratio of 2.76x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.25x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 3.33x to 2.76x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.76 | 2.76 | 2.94 | 3.33 | 2.97 | 3.04 | 2.87 | 3.02 | 2.90 | 3.14 | 3.15 |
| Quick Ratio | 1.25 | 1.25 | 1.64 | 1.75 | 1.61 | 1.72 | 1.62 | 1.74 | 1.66 | 1.75 | 1.61 |
| Cash Ratio | 0.26 | 0.26 | 0.56 | 0.46 | 0.48 | 0.57 | 0.58 | 0.53 | 0.55 | 0.48 | 0.31 |
| Asset Turnover | — | 0.95 | 1.04 | 1.01 | 1.01 | 0.99 | 1.02 | 1.14 | 1.22 | 1.23 | 1.23 |
| Inventory Turnover | 2.02 | 2.02 | 2.65 | 2.45 | 2.53 | 2.60 | 2.76 | 2.84 | 3.10 | 3.20 | 3.06 |
| Days Sales Outstanding | — | 64.20 | 60.78 | 61.02 | 64.51 | 64.32 | 57.70 | 70.10 | 60.42 | 60.10 | 60.12 |
PAHC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Phibro Animal Health Corporation returns 0.8% to shareholders annually primarily through dividends. A payout ratio of 40.3% is moderate and appears sustainable, balancing shareholder returns with reinvestment capacity. The earnings yield of 2.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.8% | 1.9% | 2.9% | 3.5% | 2.5% | 1.7% | 1.8% | 1.4% | 0.9% | 1.1% | 2.1% |
| Payout Ratio | 40.3% | 40.3% | 804.7% | 59.6% | 39.5% | 35.7% | 57.9% | 34.0% | 24.8% | 24.5% | 19.0% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.0% | 4.7% | 0.4% | 5.9% | 6.3% | 4.6% | 3.2% | 4.2% | 3.5% | 4.3% | 11.1% |
| FCF Yield | 1.8% | 4.0% | 6.8% | — | — | 1.6% | 2.4% | 1.3% | 2.8% | 5.2% | 0.1% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.8% | 1.9% | 2.9% | 3.5% | 2.5% | 1.7% | 1.8% | 1.4% | 0.9% | 1.1% | 2.1% |
| Shares Outstanding | — | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $40M | $40M | $40M |
Peer Comparison
Compare PAHC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PAHCYou | $2B | 49.3 | 19.7 | 56.8 | 30.9% | 8.5% | 17.8% | 9.8% | 4.9 |
 ELAN | $13B | -55.7 | 17.7 | 46.0 | 43.5% | 5.3% | -3.7% | 1.9% | 4.3 |
 ZTS | $47B | 18.5 | 13.3 | 20.6 | 70.5% | 38.0% | 66.0% | 26.9% | 2.3 |
 NEOG | $2B | -1.8 | 20.6 | — | 47.1% | 1.1% | -41.9% | 0.2% | 6.8 |
 IDXX | $46B | 44.3 | 32.1 | 43.8 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 |
 TSN | $24B | 50.1 | 11.4 | 20.6 | 6.5% | 2.6% | 2.6% | 4.1% | 3.2 |
 HRL | $11B | 23.8 | 13.8 | 21.3 | 15.6% | 5.9% | 6.0% | 5.3% | 2.9 |
 PPC | $7B | 6.9 | 4.9 | 11.3 | 12.7% | 8.7% | 27.2% | 20.0% | 1.6 |
 CAG | $7B | 5.8 | 8.5 | 5.2 | 25.9% | 11.8% | 12.9% | 6.0% | 4.7 |
 DE | $160B | 32.0 | 20.3 | 49.6 | 36.5% | 18.8% | 19.3% | 7.7% | 6.0 |
 CTVA | $55B | 51.1 | 13.9 | 19.5 | 43.6% | 15.1% | 4.5% | 8.5% | 0.7 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 22 years · Updated daily
See PAHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PAHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PAHC vs ELAN
Side-by-side business, growth, and profitability comparison vs Elanco Animal Health Incorporated.
Start ComparisonPAHC — Frequently Asked Questions
Quick answers to the most common questions about buying PAHC stock.
What is Phibro Animal Health Corporation's P/E ratio?
Phibro Animal Health Corporation's current P/E ratio is 49.3x. The historical average is 21.7x. This places it at the 100th percentile of its historical range.
What is Phibro Animal Health Corporation's EV/EBITDA?
Phibro Animal Health Corporation's current EV/EBITDA is 19.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.1x.
What is Phibro Animal Health Corporation's ROE?
Phibro Animal Health Corporation's return on equity (ROE) is 17.8%. The historical average is 38.9%.
Is PAHC stock overvalued?
Based on historical data, Phibro Animal Health Corporation is trading at a P/E of 49.3x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Phibro Animal Health Corporation's dividend yield?
Phibro Animal Health Corporation's current dividend yield is 0.81% with a payout ratio of 40.3%.
What are Phibro Animal Health Corporation's profit margins?
Phibro Animal Health Corporation has 30.9% gross margin and 8.5% operating margin.
How much debt does Phibro Animal Health Corporation have?
Phibro Animal Health Corporation's Debt/EBITDA ratio is 4.9x, indicating high leverage. A ratio above 4x may signal elevated financial risk.